Bellerophon Therapeutics Financials
We suggest to use Bellerophon Therapeutics fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Bellerophon Therapeutics is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate data for thirty-four available fundamental indicators for Bellerophon Therapeutics, which can be compared to its peers.
Bellerophon |
Understanding current and past Bellerophon Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bellerophon Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Bellerophon Therapeutics' assets may result in an increase in income on the income statement.
Bellerophon Therapeutics Stock Summary
Bellerophon Therapeutics competes with Capricor Therapeutics, NextCure, Zura Bio, Immix Biopharma, and Enveric Biosciences. Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Bellerophon Ther operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US0787713009 |
| Business Address | 184 Liberty Corner |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bellerophon.com |
| Phone | 908 574 4770 |
| Currency | USD - US Dollar |
Bellerophon Therapeutics Key Financial Ratios
Bellerophon Therapeutics' financial ratios allow both analysts and investors to convert raw data from Bellerophon Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Bellerophon Therapeutics over time and compare it to other companies across industries.Bellerophon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bellerophon Therapeutics's current stock value. Our valuation model uses many indicators to compare Bellerophon Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bellerophon Therapeutics competition to find correlations between indicators driving Bellerophon Therapeutics's intrinsic value. More Info.Bellerophon Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bellerophon Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bellerophon Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |